You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment naïve Advanced Non-Small Cell Lung Cancer (NSCLC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Trial in New York (Pembrolizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • New York, New York
    Mount Sinai Hospital
Jan 23, 2023

NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +8 more
  • New Haven, Connecticut
    Yale University
Oct 26, 2022

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

NSCLC Trial in Worldwide (Repotrectinib, Crizotinib)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Augusta, Georgia
  • +40 more
Nov 29, 2023

NSCLC (NSCLC) Trial in Tampa (PBF-509_80 mg, PBF-509_160 mg, PBF-509_320 mg)

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • PBF-509_80 mg
  • +8 more
  • Tampa, Florida
    H.Lee Moffitt Cancer center
Jan 3, 2022

Stage IIIA NSCLC, Stage IIIB NSCLC, Stage IV NSCLC Trial in Los Angeles (Laboratory Biomarker Analysis, Pembrolizumab)

Completed
Has Results
  • Stage IIIA Non-Small Cell Lung Cancer
  • +2 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 24, 2021

NSCLC Trial in Xiamen (Icotinib, Befotertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Xiamen, Fujian, China
    Feng Ye
Sep 17, 2021

NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

Terminated
  • Non-small Cell Lung Cancer
  • Davis, California
  • +1 more
Dec 22, 2022

Treatment-naive Advanced NSCLC Trial in Beijing (TORIPALIMAB INJECTION (JS001 ) combine with chemo)

Recruiting
  • Treatment-naive Advanced Non-small Cell Lung Cancer
  • TORIPALIMAB INJECTION (JS001 ) combine with chemotherapy
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Sep 28, 2020

Advanced NSCLC Trial (BNT116, Cemiplimab)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Jan 3, 2023

Lung Cancer, NSCLC Trial in Tampa (Vorinostat, Pembrolizumab)

Active, not recruiting
  • Lung Cancer
  • Non-small Cell Lung Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022

Advanced NSCLC Trial (fianlimab, cemiplimab, Placebo)

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • (no location specified)
Mar 27, 2023

NSCLC, Urothelial Cancer Trial in Worldwide (Avelumab (MSB0010718C), Axitinib (AG-013736))

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • Urothelial Cancer
  • Avelumab (MSB0010718C)
  • Axitinib (AG-013736)
  • Glendale, Arizona
  • +36 more
Aug 16, 2022

Metastatic Non Small Cell Lung Cancer Trial in Worldwide (Datopotamab Deruxtecan, Pembrolizumab)

Recruiting
  • Metastatic Non Small Cell Lung Cancer
  • Chandler, Arizona
  • +32 more
Aug 12, 2022

Non-Small-Cell Lung Cancer Trial in Guangzhou (PLB1004)

Recruiting
  • Non-Small-Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong General Hospital
Aug 25, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

Not yet recruiting
  • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
  • New York, New York
    NYU Langone Health
Apr 4, 2023

ALK Positive NSCLC Trial in Guangzhou (Loratinib)

Recruiting
  • ALK Positive Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Guangdong Provincial Perople's Hospital
Oct 19, 2023

NSCLC (NSCLC) Trial (MK-2870, Docetaxel, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • MK-2870
  • +2 more
  • (no location specified)
Oct 3, 2023

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

NSCLC Trial in Houston (Amivantamab, Tepotinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

NSCLC Trial (Sutetinib Maleate Capsule)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Sutetinib Maleate Capsule
  • (no location specified)
Aug 18, 2023

Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

Recruiting
  • Nonsmall Cell Lung Cancer
  • +3 more
  • Genomically Guided Radiation Therapy (RT)
  • Tampa, Florida
    Moffitt Cancer Center
May 23, 2023

NSCLC, NSCLC, PD-1 Trial in Beijing (F520, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Feb 22, 2023

Locally Advanced or Metastatic NSCLC Trial (HB1801, Taxotere)

Not yet recruiting
  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  • (no location specified)
May 8, 2023